Botulinum Toxin for Spasticity in Children With Cerebral Palsy: A Comprehensive Evaluation

2007155 citationsJournal Articlegreen Open Access

Authors

Kristie Bjornson · Seattle Children's Hospital

Ron D. Hays · University of Washington

Cathy Graubert · Seattle Children's Hospital

Robert Price · University of Washington

Francine Won · Seattle Children's Hospital

John F. McLaughlin · University of Washington

Morty Cohen ·

Abstract

The safety profile of 12 U/kg of botulinum toxin A is excellent. Although physiologic and mechanical effects of treatment with botulinum toxin A were documented with functional improvement at 6 months, family satisfaction with outcomes were no different. Communication is needed to ensure realistic expectations of treatment.

Topics & Keywords

Botulinum Toxin and Related Neurological Disorders Cerebral Palsy and Movement Disorders Stroke Rehabilitation and Recovery

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: PEDIATRICS

Volume 120, Issue 1, pp. 49-58

DOI: 10.1542/peds.2007-0016

Field-Weighted Citation Impact: 7.04